ILMN

Illumina, Inc. NASDAQ

Healthcare ·Medical - Diagnostics & Research ·US · illumina.com

$139.37

Mkt Cap $21.2B

52w Low $73.86 80.2% of range 52w High $155.53

50d MA $125.85 200d MA $118.05

P/E (TTM) 24.8x

EV/EBITDA 14.9x

P/B 7.6x

Debt/Equity 0.9x

ROE 31.2%

P/FCF 22.1x

RSI (14) —

ATR (14) —

Beta 1.49

50d MA $125.85

200d MA $118.05

Avg Volume 1.8M

About

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables use…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 30, 2026	AMC	1.05	1.15	+9.5%	126.74	+5.1%	+7.1%	+10.0%	+10.0%	—	—	—
Feb 5, 2026	AMC	1.24	1.35	+8.9%	133.61	-5.7%	-10.4%	-12.2%	-10.7%	-12.9%	-14.3%	—
Oct 30, 2025	AMC	1.17	1.34	+14.5%	99.01	+8.0%	+24.8%	+21.2%	+18.0%	+23.7%	+22.3%	—
Jul 31, 2025	AMC	1.02	1.19	+16.7%	102.71	-9.8%	-7.8%	-4.2%	-4.8%	-8.1%	-7.0%	—
May 8, 2025	AMC	0.94	0.97	+3.2%	79.58	-0.1%	-4.8%	+2.5%	+0.9%	-1.7%	+1.7%	—
Feb 6, 2025	AMC	0.92	0.86	-6.5%	122.80	-9.4%	-9.6%	-14.5%	-18.0%	-15.7%	-17.1%	—
Nov 4, 2024	AMC	0.88	1.14	+29.7%	153.49	-3.5%	+1.0%	-1.1%	+1.1%	-1.6%	-1.3%	—
Aug 6, 2024	AMC	0.11	0.36	+228.5%	116.36	+3.0%	+4.1%	+8.9%	+6.2%	+7.0%	+2.9%	—
May 2, 2024	AMC	0.04	0.09	+106.4%	120.50	+2.5%	-4.9%	-4.0%	-9.0%	-10.8%	-10.2%	—
Feb 8, 2024	AMC	0.02	0.14	+686.1%	139.29	+0.3%	-3.8%	-2.3%	-6.7%	-1.8%	+1.9%	—
Nov 9, 2023	AMC	0.13	0.33	+153.8%	103.97	-12.1%	-8.1%	-13.3%	-8.9%	-6.4%	-11.0%	—
Aug 9, 2023	AMC	0.02	0.32	+1636.5%	179.29	-3.0%	+0.3%	-2.2%	-5.1%	-4.6%	-8.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	Barclays	Maintains	Underweight → Underweight	—	$126.74	$133.22	+5.1%	+7.1%	—	—	—	—
May 1	Evercore ISI	Maintains	Outperform → Outperform	—	$126.74	$133.22	+5.1%	+7.1%	—	—	—	—
May 1	JP Morgan	Maintains	Neutral → Neutral	—	$126.74	$133.22	+5.1%	+7.1%	—	—	—	—
May 1	Canaccord Genuity	Maintains	Hold → Hold	—	$126.74	$133.22	+5.1%	+7.1%	—	—	—	—
Feb 9	Piper Sandler	Maintains	Overweight → Overweight	—	$119.72	$119.72	+0.0%	-2.1%	-0.3%	-2.8%	-4.4%	-2.4%
Feb 6	JP Morgan	Maintains	Neutral → Neutral	—	$133.61	$125.99	-5.7%	-10.4%	-12.2%	-10.7%	-12.9%	-14.3%
Jan 26	Guggenheim	Maintains	Buy → Buy	—	$150.28	$149.36	-0.6%	+1.8%	+1.2%	-0.3%	-0.4%	-3.6%
Jan 26	Canaccord Genuity	Maintains	Hold → Hold	—	$150.28	$149.36	-0.6%	+1.8%	+1.2%	-0.3%	-0.4%	-3.6%
Jan 20	Stifel	Maintains	Buy → Buy	—	$141.65	$137.78	-2.7%	+3.9%	+7.6%	+8.7%	+6.1%	+8.0%
Jan 7	TD Cowen	Maintains	Hold → Hold	—	$147.11	$146.95	-0.1%	+2.1%	-0.9%	-4.1%	-1.1%	-0.1%
Jan 5	Guggenheim	Maintains	Buy → Buy	—	$134.35	$134.36	+0.0%	+5.2%	+9.5%	+11.8%	+8.5%	+5.0%
Dec 22	Canaccord Genuity	Maintains	Hold → Hold	—	$134.78	$135.60	+0.6%	+2.1%	+1.0%	+0.4%	+0.1%	-0.2%
Dec 15	JP Morgan	Maintains	Neutral → Neutral	—	$134.87	$134.90	+0.0%	+0.0%	-2.5%	-3.9%	-3.2%	-0.1%
Dec 15	Barclays	Maintains	Underweight → Underweight	—	$134.87	$134.90	+0.0%	+0.0%	-2.5%	-3.9%	-3.2%	-0.1%
Oct 31	Barclays	Maintains	Underweight → Underweight	—	$99.01	$106.91	+8.0%	+24.8%	+21.2%	+18.0%	+23.7%	+22.3%
Oct 31	Evercore ISI	Maintains	Outperform → Outperform	—	$99.01	$106.91	+8.0%	+24.8%	+21.2%	+18.0%	+23.7%	+22.3%
Oct 31	Baird	Maintains	Neutral → Neutral	—	$99.01	$106.91	+8.0%	+24.8%	+21.2%	+18.0%	+23.7%	+22.3%
Oct 31	JP Morgan	Maintains	Neutral → Neutral	—	$99.01	$106.91	+8.0%	+24.8%	+21.2%	+18.0%	+23.7%	+22.3%
Oct 31	UBS	Maintains	Neutral → Neutral	—	$99.01	$106.91	+8.0%	+24.8%	+21.2%	+18.0%	+23.7%	+22.3%
Oct 31	Canaccord Genuity	Maintains	Hold → Hold	—	$99.01	$106.91	+8.0%	+24.8%	+21.2%	+18.0%	+23.7%	+22.3%
Oct 31	TD Cowen	Maintains	Hold → Hold	—	$99.01	$106.91	+8.0%	+24.8%	+21.2%	+18.0%	+23.7%	+22.3%
Oct 7	Evercore ISI	Maintains	Outperform → Outperform	—	$101.02	$101.36	+0.3%	-4.3%	-3.2%	-4.5%	-7.1%	-5.9%
Oct 2	Barclays	Maintains	Underweight → Underweight	—	$102.26	$103.00	+0.7%	-2.9%	-0.1%	-1.2%	-5.5%	-4.4%
Aug 4	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$94.66	$95.03	+0.4%	+4.0%	+3.3%	-0.2%	+0.9%	-0.1%
Aug 1	Barclays	Maintains	Underweight → Underweight	—	$102.71	$92.61	-9.8%	-7.8%	-4.2%	-4.8%	-8.1%	-7.0%
Aug 1	UBS	Maintains	Neutral → Neutral	—	$102.71	$92.61	-9.8%	-7.8%	-4.2%	-4.8%	-8.1%	-7.0%
Aug 1	RBC Capital	Maintains	Outperform → Outperform	—	$102.71	$92.61	-9.8%	-7.8%	-4.2%	-4.8%	-8.1%	-7.0%
Aug 1	Canaccord Genuity	Maintains	Hold → Hold	—	$102.71	$92.61	-9.8%	-7.8%	-4.2%	-4.8%	-8.1%	-7.0%
Aug 1	JP Morgan	Maintains	Neutral → Neutral	—	$102.71	$92.61	-9.8%	-7.8%	-4.2%	-4.8%	-8.1%	-7.0%
Jul 28	Baird	Maintains	Neutral → Neutral	—	$109.30	$109.40	+0.1%	+0.5%	-0.5%	-2.4%	-6.0%	-13.4%
Jul 11	Scotiabank	Downgrade	Sector Outperform → Sector Perform	—	$100.05	$98.50	-1.5%	-0.8%	-1.5%	-2.9%	-3.1%	-2.1%
Jul 9	Citigroup	Downgrade	Neutral → Sell	—	$99.27	$96.25	-3.0%	-1.8%	+0.8%	-0.0%	-0.7%	-2.1%
Jul 8	Evercore ISI	Maintains	Outperform → Outperform	—	$97.15	$97.42	+0.3%	+2.2%	+0.3%	+3.0%	+2.2%	+1.4%
Jun 24	Barclays	Maintains	Underweight → Underweight	—	$90.61	$91.54	+1.0%	+1.0%	+2.9%	+3.9%	+4.6%	+5.3%
Jun 11	Canaccord Genuity	Maintains	Hold → Hold	—	$87.98	$88.91	+1.1%	-0.5%	+0.2%	-1.2%	+2.6%	+1.7%
May 20	Stephens & Co.	Maintains	Overweight → Overweight	—	$82.95	$82.91	-0.0%	+1.5%	-4.3%	-2.9%	-3.1%	-0.6%
May 15	Piper Sandler	Maintains	Overweight → Overweight	—	$78.21	$80.02	+2.3%	+3.4%	+6.9%	+6.1%	+7.7%	+1.5%
May 12	Canaccord Genuity	Maintains	Hold → Hold	—	$75.76	$79.28	+4.6%	+7.7%	+6.0%	+3.2%	+6.8%	+10.4%
May 12	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$75.76	$79.28	+4.6%	+7.7%	+6.0%	+3.2%	+6.8%	+10.4%
May 9	Guggenheim	Maintains	Buy → Buy	—	$79.58	$79.50	-0.1%	-4.8%	+2.5%	+0.9%	-1.7%	+1.7%
May 9	JP Morgan	Maintains	Neutral → Neutral	—	$79.58	$79.50	-0.1%	-4.8%	+2.5%	+0.9%	-1.7%	+1.7%
Apr 29	Canaccord Genuity	Maintains	Hold → Hold	—	$77.22	$76.61	-0.8%	-0.2%	+0.5%	-0.9%	+0.9%	+1.2%
Apr 10	Barclays	Maintains	Underweight → Underweight	—	$76.30	$74.50	-2.4%	-6.6%	-2.0%	-1.6%	-2.2%	-3.6%
Apr 8	RBC Capital	Maintains	Outperform → Outperform	—	$73.45	$75.76	+3.1%	-4.3%	+3.9%	-3.0%	+1.8%	+2.2%
Apr 7	Citigroup	Maintains	Neutral → Neutral	—	$74.16	$70.61	-4.8%	-1.0%	-5.2%	+2.9%	-3.9%	+0.8%
Mar 12	RBC Capital	Maintains	Outperform → Outperform	—	$84.52	$84.63	+0.1%	-0.4%	-0.6%	+1.3%	+1.4%	+0.8%
Mar 11	Canaccord Genuity	Maintains	Hold → Hold	—	$85.97	$88.50	+2.9%	-1.7%	-2.1%	-2.2%	-0.4%	-0.3%
Mar 11	Stephens & Co.	Maintains	Overweight → Overweight	—	$85.97	$88.50	+2.9%	-1.7%	-2.1%	-2.2%	-0.4%	-0.3%
Mar 5	Baird	Maintains	Neutral → Neutral	—	$84.89	$85.00	+0.1%	+0.9%	-0.3%	+2.0%	+1.3%	-0.4%
Mar 4	Citigroup	Maintains	Neutral → Neutral	—	$84.20	$80.74	-4.1%	+0.8%	+1.8%	+0.5%	+2.9%	+2.1%

Recent Filings

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

I cannot provide a meaningful analysis as the filing excerpt lacks essential details about the executive change at Illumina, including who departed, their role, and replacement plans—information critical for assessing leadership stability and strategic direction impacts.

Apr 2

8-K

Illumina Inc -- 8-K Filing

Illumina reported its Q4 and full-year 2025 financial results, providing investors with updates on the company's revenue, profitability, and operational performance for the completed fiscal period.

Feb 5

Data updated apr 25, 2026 3:14pm · Source: massive.com